VC Playbook: Hubert Birner, managing partner for Montreal and Munich, is responsible for TVM Capital Life Science’s overall investment approach and global fund operations. At the November 2023 BIO-Europe conference, he sat down with In Vivo to discuss the VC’s strategy and expectations for the European life science sector in 2024.

CardioDx appoints president and CEO; FDA device review veteran joins Hogan Lovells; TransEnterix names new senior surgical office; and more personnel updates from around the industry.

Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, Alliance, and Financing activity.